PRACTICE QUESTIONS Flashcards
(130 cards)
Which of the following drugs are classified as
glycoprotein IIb and IIIa inhibitors?
i. Cilostazol
ii. Eptifibatide
iii. Tirofiban
iv. Dipyridamole
A. i and ii
B. ii and iii
C. i, ii, and iii
D. ii and iv
E. All of the above
B. ii and iii
The mechanism of action of clopidogrel includes all of the following except:
A. Block ADP receptors on platelets
B. Prevent ADP-induced platelet aggregation
C. Inhibit thromboxane synthesis
D. Reduce risk of thrombotic events
E. Decrease platelet adhesion
C. Inhibit thromboxane synthesis
Mrs. Evans, a 45-year-old woman with peripheral artery disease, is prescribed a phosphodiesterase inhibitor to improve her walking distance and reduce her symptoms of intermittent claudication. Which medication is Mrs. Evans most likely prescribed?
A. Cilostazol
B. Clopidogrel
C. Aspirin
D. Eptifibatide
E. Tirofiban
A. Cilostazol
Which of the following statements describe the
mechanism of action of aspirin?
i. Inhibits cyclooxygenase (COX) enzyme
ii. Prevents the formation of thromboxane A2 (TXA2)
iii. Reduces platelet aggregation
iv. Increases prostaglandin production
A. i and ii
B. ii and iii
C. i, ii, and iii
D. ii and iv
E. All of the above
C. i, ii, and iii
Ms. Smith, a 60-year-old woman on aspirin therapy, requires emergency
surgery. Her healthcare provider needs to manage her risk of bleeding during
the procedure. What is the recommended action for managing aspirin therapy before Ms. Smith’s emergency surgery?
A. Administer platelet transfusion
B. Increase aspirin dose
C. Continue aspirin without changes
D. Discontinue aspirin 7-10 days before surgery
E. Reduce aspirin dose gradually
A. Administer platelet transfusion
Which of the following are uses of ADP inhibitors?
i. Prevention of thrombotic events in patients with acute coronary syndrome
ii. Secondary prevention of myocardial infarction
iii. Prevention of stroke
iv. Treatment of deep vein thrombosis
A. i and ii
B. ii and iii
C. i, ii, and iii
D. i and iii
E. All of the above
C. i, ii, and iii
Which of the following are side effects specifically associated with Ticlopidine?
i. Neutropenia
ii. Thrombotic thrombocytopenic purpura (TTP)
iii. Diarrhea
iv. Agranulocytosis
A. i and ii
B. ii and iii
C. i, ii, and iii
D. i and iii
E. All of the above
E. All of the above
Which of the following are true statements about Clopidogrel and CYP2C19?
i. Clopidogrel is a prodrug
ii. CYP2C19 is necessary for the activation of
Clopidogrel
iii. Poor metabolizers of CYP2C19 may have reduced
therapeutic effects of Clopidogrel
iv. Clopidogrel is unaffected by CYP2C19
polymorphisms
A. i and ii
B. ii and iii
C. i, ii, and iii
D. i and iii
E. All of the above
C. i, ii, and iii
Mr. Johnson, a 55-year-old man undergoing
percutaneous coronary intervention (PCI), is
administered a glycoprotein IIb and IIIa inhibitor to prevent platelet aggregation and thrombus
formation during the procedure. Which medication is Mr. Johnson most likely receiving?
A. Abciximab
B. Clopidogrel
C. Ticagrelor
D. Aspirin
E. Warfarin
A. Abciximab
All of the following are key components of the
intrinsic pathway in the coagulation cascade except:
A. Factor XII
B. Factor XI
C. Factor IX
D. Factor VII
E. Factor VIII
D. Factor VII
Which of the following factors is involved in the
common pathway of the coagulation cascade?
A. Factor X
B. Factor VII
C. Tissue factor (TF)
D. Factor XII
E. Factor XI
A. Factor X
Which of the following is also known as Factor II in the coagulation cascade?
A. Prothrombin
B. Fibrinogen
C. Antihemophilic factor
D. Stuart-Prower factor
E. Proconvertin
A. Prothrombin
Which of the following is also known as Factor VII in the coagulation cascade?
A. Proconvertin
B. Stuart-Prower factor
C. Prothrombin
D. Fibrinogen
E. Proaccelerin
A. Proconvertin
Which of the following molecules play a role in
platelet adhesion?
i. von Willebrand factor (vWF)
ii. Glycoprotein Ib (GpIb)
iii. Fibrinogen
iv. Thrombin
A. i and ii
B. ii and iii
C. i, ii, and iv
D. ii and iv
E. All of the above
A. i and ii
Which of the following molecules are involved in
platelet activation?
i. Adenosine diphosphate (ADP)
ii. Thromboxane A2 (TXA2)
iii. Serotonin
iv. Calcium ions (Ca2+)
A. i and ii
B. ii and iii
C. i, ii, and iv
D. i and iii
E. All of the above
E. All of the above
Which of the following are platelet pro-aggregants?
i. Thromboxane A2 (TXA2)
ii. Adenosine diphosphate (ADP)
iii. Serotonin
iv. Prostacyclin (PGI2)
A. i and ii
B. ii and iii
C. i, ii, and iii
D. ii and iv
E. All of the above
C. i, ii, and iii
Which of the following hormones are regulated by the hypothalamus?
i. Growth hormone (GH)
ii. Follicle-stimulating hormone (FSH)
iii. Thyroid-stimulating hormone (TSH)
iv. Epinephrine
A. i and ii
B. ii, iii, and iv
C. i, ii, and iii
D. ii and iv
E. All of the above
C. i, ii, and iii
Which of the following are hormones produced by the thyroid gland?
i. T3 (Triiodothyronine)
ii. T4 (Thyroxine)
iii. Calcitonin
iv. Glucagon
A. i and ii
B. i, ii, and iii
C. ii, iii, and iv
D. i and iii
E. All of the above
B. i, ii, and iii
A 40-year-old woman presents with symptoms of decreased metabolic rate, fatigue, and unexplained weight gain. Laboratory results indicate decreased levels of T3 and T4, accompanied by an elevated TSH level. Which endocrine gland is primarily malfunctioning, and which hormone(s) are deficient in this condition?
A. Adrenal gland; aldosterone
B. Pituitary gland; growth hormone
C. Thyroid gland; T3 and T4
D. Pancreas; glucagon
E. Hypothalamus; thyrotropin-releasing hormone
C. Thyroid gland; T3 and T4
A patient presents with symptoms consistent with hypercalcemia, including fatigue, digestive issues, and bone pain. Laboratory tests reveal elevated levels of parathyroid hormone (PTH). Which of the following hormones are produced by the anterior pituitary gland?
i. Growth hormone (GH)
ii. Prolactin
iii. Thyroid-stimulating hormone (TSH)
iv. Oxytocin
A. i and ii
B. i, ii, and iii
C. ii, iii, and iv
D. i and iii
E. All of the above
B. i, ii, and iii
A patient presents with galactorrhea and
hypogonadism due to hyperprolactinemia. Which drug would be most appropriate to treat this condition, and what is its mechanism of action?
A. Bromocriptine; D2 receptor agonist
B. Octreotide; somatostatin analog
C. Somatropin; stimulates IGF-1 production
D. Insulin; regulates blood sugar levels
E. Vasopressin; regulates water balance
A. Bromocriptine; D2 receptor agonist
A 60-year-old patient with a history of cirrhosis
presents with bleeding esophageal varices. The
healthcare provider prescribes a somatostatin
analog. Which drug is being used, and what is its
primary effect?
A. Octreotide; vasoconstriction
B. Bromocriptine; reduces prolactin levels
C. Somatropin; promotes growth
D. Insulin; lowers blood sugar levels
E. Corticotropin; increases cortisol secretion
A. Octreotide; vasoconstriction
Which of the following are functions of oxytocin?
i. Stimulates uterine contractions (oxytosis)
ii. Causes milk ejection (let-down)
iii. Regulates water reabsorption in the kidney
iv. Promotes vasoconstriction
A. i and ii
B. ii and iii
C. i, ii, and iii
D. ii and iv
E. All of the above
A. i and ii
A 45-year-old man presents with symptoms of
polydipsia, polyuria, and nocturia. Further testing reveals decreased ADH secretion. What is the likely diagnosis, and what is the treatment?
A. Central diabetes insipidus; treated with vasopressin or desmopressin
B. SIADH; treated with demeclocycline
C. Nephrogenic diabetes insipidus; treated with thiazide diuretics
D. Addison’s disease; treated with cortisol
E. Cushing’s syndrome; treated with spironolactone
A. Central diabetes insipidus; treated with vasopressin or desmopressin